Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets (Q34209542)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Sandeep Dutta

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

0 references

publication date

1 July 2014

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

78

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

94-105

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Pharmacokinetics of levodopa/carbidopa delivered from gastric-retentive extended-release formulations in patients with Parkinson's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Alzheimer's disease and Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Levodopa in the treatment of Parkinson's disease: a consensus meeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Population Pharmacokinetics/Dynamics*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

5 July 2018

Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12324

21 January 2018

Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12324

21 January 2018

Duodenal levodopa infusion in Parkinson's disease--long-term experience

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12324

21 January 2018

Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12324

21 January 2018

Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12324

21 January 2018

Importance of within subject variation in levodopa pharmacokinetics: a 4 year cohort study in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12324

21 January 2018

Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12324

21 January 2018

Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12324

21 January 2018

A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168384

28 October 2018

Pharmacokinetics and pharmacodynamics of levodopa

1 reference

https://pubmed.ncbi.nlm.nih.gov/24433449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/BCP.12324

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24433449%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34209542&oldid=1543925031"